WINDTREE THERAPEUTICS INC /DE/
DelistedCIK 946486fmd_0TTTVBQR070R6YYV0JZYMK5AWYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2010 to Sep 30, 2025, 62 periods
Latest annual · FY2019
Millions- Total revenues
- 0
- Operating income
- (26)
- Net income
- (2)
- Free cash flow
- (15)
Latest quarter · Q3 FY2025
Millions- Operating income
- (20)
- Net income
- (28)
- Free cash flow
- (6)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2019 to FY2024
- n/m
WINDTREE THERAPEUTICS INC /DE/ financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$26.1 million | -$20.6 million | 10-K 2025-04-15 · proof | |
| Net income | -$1.8 million | -$20.3 million | 10-K 2025-04-15 · proof | |
| Cash from operating activities | -$15.4 million | -$13.4 million | 10-K 2025-04-15 · proof | |
| Free cash flow | -$15.4 million | -$13.5 million | 10-K 2025-04-15 · proof | |
| Total assets | $27.9 million | $32.4 million | -14% | 10-K 2025-04-15 · proof |
| Total liabilities | $14.7 million | $29 million | -49.3% | 10-K 2025-04-15 · proof |
| Cash and cash equivalents | $1.8 million | $4.3 million | -58.8% | 10-K 2025-04-15 · proof |
- What was WINDTREE THERAPEUTICS INC /DE/'s operating income in fiscal 2024?
- WINDTREE THERAPEUTICS INC /DE/ reported operating income of -$26.1 million for fiscal 2024 (the year ended Dec 31, 2024), against -$20.6 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What was WINDTREE THERAPEUTICS INC /DE/'s net income in fiscal 2024?
- WINDTREE THERAPEUTICS INC /DE/ reported net income of -$1.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$20.3 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What was WINDTREE THERAPEUTICS INC /DE/'s cash from operating activities in fiscal 2024?
- WINDTREE THERAPEUTICS INC /DE/ reported cash from operating activities of -$15.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$13.4 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What was WINDTREE THERAPEUTICS INC /DE/'s free cash flow in fiscal 2024?
- WINDTREE THERAPEUTICS INC /DE/ reported free cash flow of -$15.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$13.5 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What are WINDTREE THERAPEUTICS INC /DE/'s total assets?
- As of Dec 31, 2024, WINDTREE THERAPEUTICS INC /DE/ reported total assets of $27.9 million, against $32.4 million a year earlier (-14%). Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What are WINDTREE THERAPEUTICS INC /DE/'s total liabilities?
- As of Dec 31, 2024, WINDTREE THERAPEUTICS INC /DE/ reported total liabilities of $14.7 million, against $29 million a year earlier (-49.3%). Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
- What are WINDTREE THERAPEUTICS INC /DE/'s cash and cash equivalents?
- As of Dec 31, 2024, WINDTREE THERAPEUTICS INC /DE/ reported cash and cash equivalents of $1.8 million, against $4.3 million a year earlier (-58.8%). Source: the 10-K filed with the SEC on Apr 15, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:946486&period_type=annual&limit=5"Information only, not investment advice.